Resmonics
Latest round
- Seed
Last raised
- Nov 2020
Total raised
- $0M
Investors
- 1
About Resmonics
Resmonics AG was founded in 2020 and is headquartered in Zurich, Switzerland. The company specializes in creating solutions that enhance hygiene compliance in healthcare environments. The founders, David Cleres, Matthias Groh, and Peter Tinschert, have prior entrepreneurial experiences.Resmonics AG specializes in advanced solutions for infection prevention and hygiene management within healthcare environments, primarily through its flagship product, Resmonics AI. This automated system leverages artificial intelligence and Internet of Things (IoT) technology to monitor hand and surface disinfectant usage in real-time, providing healthcare professionals with critical insights necessary for making informed decisions regarding patient and staff safety. The ResGuard Med software, certified as a medical device, detects and analyzes ambient respiratory symptoms to anticipate potential infection waves, thereby enabling proactive measures against healthcare-associated infections. The company targets hospitals and healthcare networks across various geographical markets including Europe and North America, aiming to enhance hygiene compliance and reduce the incidence of nosocomial infections.Resmonics AG generates revenue through a subscription-based model for its advanced hygiene monitoring solutions, allowing healthcare providers to access real-time data and insights tailored to their operational needs. Customers typically enter into service agreements that facilitate ongoing monitoring and support, thereby ensuring compliance with health standards and improving overall hygiene practices. The pricing structure is designed to meet the needs of mid-sized to large hospitals, focusing on the scalability of its solutions to accommodate varying operational sizes and complexities.Resmonics AG plans to enhance its product offerings with new innovations designed to further aid infection prevention, although specific upcoming products and release dates were not disclosed. The company aims to expand its presence in both European and North American markets by the end of 2022.
Who invested in Resmonics
1 investor across 1 round
See all investors in Resmonics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 24, 2020
Amount
$0M
Investors
Questions about Resmonics
Who invested in Resmonics?
Resmonics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Resmonics raised?
Resmonics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Resmonics last raise money?
Resmonics's most recent round on record is a Seed, in Nov 2020.
What does Resmonics do?
Resmonics AG was founded in 2020 and is headquartered in Zurich, Switzerland.
Where is Resmonics headquartered?
Resmonics is headquartered in Zurich, Switzerland.
Which VCs invest in companies like Resmonics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at Resmonics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Resmonics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.